agilon health (NYSE:AGL) Stock Rating Reaffirmed by Benchmark

Benchmark restated their buy rating on shares of agilon health (NYSE:AGLFree Report) in a research note issued to investors on Thursday morning, Benzinga reports. Benchmark currently has a $9.00 target price on the stock.

Several other research firms have also issued reports on AGL. Truist Financial boosted their target price on shares of agilon health from $6.40 to $6.50 and gave the stock a hold rating in a report on Friday, May 24th. Stifel Nicolaus lowered their price objective on shares of agilon health from $8.00 to $7.00 and set a hold rating for the company in a research note on Wednesday, May 1st. Citigroup started coverage on agilon health in a research report on Monday, April 22nd. They issued a neutral rating and a $6.00 target price on the stock. Evercore ISI boosted their price target on agilon health from $5.50 to $7.00 and gave the company an in-line rating in a research note on Tuesday, July 9th. Finally, Robert W. Baird assumed coverage on shares of agilon health in a report on Thursday, May 30th. They issued a neutral rating and a $6.00 price target on the stock. One research analyst has rated the stock with a sell rating, fourteen have given a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of Hold and a consensus target price of $8.57.

Get Our Latest Analysis on agilon health

agilon health Trading Down 1.3 %

agilon health stock traded down $0.07 during midday trading on Thursday, reaching $5.53. The stock had a trading volume of 5,045,390 shares, compared to its average volume of 5,138,099. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.04. The firm has a market cap of $2.27 billion, a price-to-earnings ratio of -7.89 and a beta of 0.60. agilon health has a 52-week low of $4.41 and a 52-week high of $20.37. The company has a fifty day moving average of $6.51 and a 200 day moving average of $5.99.

agilon health (NYSE:AGLGet Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). agilon health had a negative return on equity of 26.15% and a negative net margin of 5.67%. The company had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period last year, the business posted ($0.04) EPS. agilon health’s quarterly revenue was up 38.7% on a year-over-year basis. On average, analysts anticipate that agilon health will post -0.34 earnings per share for the current fiscal year.

Institutional Investors Weigh In On agilon health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Capital World Investors raised its stake in shares of agilon health by 7.4% in the 4th quarter. Capital World Investors now owns 55,218,496 shares of the company’s stock valued at $692,992,000 after acquiring an additional 3,813,214 shares during the period. Wellington Management Group LLP grew its stake in shares of agilon health by 2.9% in the fourth quarter. Wellington Management Group LLP now owns 42,510,030 shares of the company’s stock valued at $533,501,000 after buying an additional 1,191,253 shares in the last quarter. Vanguard Group Inc. lifted its stake in agilon health by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after acquiring an additional 371,537 shares in the last quarter. Capital International Investors lifted its stake in agilon health by 84.7% during the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after acquiring an additional 9,263,296 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its holdings in agilon health by 46.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,139,886 shares of the company’s stock valued at $127,256,000 after acquiring an additional 3,195,087 shares during the period.

About agilon health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles

Analyst Recommendations for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.